(Q42473812)

1 November 2017

title

beta-Agonist stimulation produces changes in cardiac AMPK and coronary lumen LPL only during increased workload (English)

1 reference

1 November 2017

Ding An

1

1 reference

1 November 2017

Girsh Kewalramani

2

1 reference

1 November 2017

Dake Qi

3

1 reference

1 November 2017

Thomas Pulinilkunnil

4

1 reference

1 November 2017

Sanjoy Ghosh

5

1 reference

1 November 2017

Ashraf Abrahani

6

1 reference

1 November 2017

Rich Wambolt

7

1 reference

1 November 2017

Michael Allard

8

1 reference

1 November 2017

Sheila M Innis

9

1 reference

1 November 2017

Brian Rodrigues

10

1 reference

1 November 2017

publication date

1 February 2005

1 reference

American Journal of Physiology - Endocrinology and Metabolism

1 November 2017

published in

1 reference

1 November 2017

volume

288

1 reference

1 November 2017

issue

6

1 reference

1 November 2017

page(s)

E1120-7

1 reference

The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase

1 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Routes of FA delivery to cardiac muscle: modulation of lipoprotein lipolysis alters uptake of TG-derived FA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Lipoprotein lipase in myocytes and capillary endothelium of heart: immunocytochemical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Sequence of rat lipoprotein lipase-encoding cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Actions of insulin on the mammalian heart: metabolism, pathology and biochemical mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Effect of exercise intensity on skeletal muscle AMPK signaling in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Mechanisms of action of dietary fatty acids in regulating the activation of vascular endothelial cells during atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Pathological sympathoexcitation: how is it achieved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Tissue-specific expression of human lipoprotein lipase in the vascular system affects vascular reactivity in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Sympathetic activation in human heart failure: diverse mechanisms, therapeutic opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Preferential oxidation of glycogen in isolated working rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Lipoprotein disorders associated with type 2 diabetes mellitus and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Minireview: the AMP-activated protein kinase cascade: the key sensor of cellular energy status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

The AMP-activated protein kinase--fuel gauge of the mammalian cell?

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Overexpression of lipoprotein lipase improves insulin resistance induced by a high-fat diet in transgenic rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Akt activity negatively regulates phosphorylation of AMP-activated protein kinase in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

5' AMP-activated protein kinase activation causes GLUT4 translocation in skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Muscle-specific overexpression of lipoprotein lipase causes a severe myopathy characterized by proliferation of mitochondria and peroxisomes in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Regulation of fatty acid oxidation in the mammalian heart in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Contraction-Induced Fatty Acid Translocase/CD36 Translocation in Rat Cardiac Myocytes Is Mediated Through AMP-Activated Protein Kinase Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Lipoprotein lipase: genetics, lipid uptake, and regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Lipoprotein lipase and its role in regulation of plasma lipoproteins and cardiac risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Endothelial cell heparanase modulation of lipoprotein lipase activity. Evidence that heparan sulfate oligosaccharide is an extracellular chaperone

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Evidence for rapid "metabolic switching" through lipoprotein lipase occupation of endothelial-binding sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Palmitoyl lysophosphatidylcholine mediated mobilization of LPL to the coronary luminal surface requires PKC activation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Circulating triglyceride lipolysis facilitates lipoprotein lipase translocation from cardiomyocyte to myocardial endothelial lining

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Beta-adrenergic receptors and regulation of energy expenditure: a family affair

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Myocardial substrate metabolism: implications for diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

AMP kinase and malonyl-CoA: targets for therapy of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Malonyl-CoA and AMP-activated protein kinase: an expanding partnership

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Short-term incubation of cardiac myocytes with isoprenaline has no effect on heparin-releasable or cellular lipoprotein lipase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Progressive increase in human skeletal muscle AMPKalpha2 activity and ACC phosphorylation during exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Enhancement of the binding of triglyceride-rich lipoproteins to the very low density lipoprotein receptor by apolipoprotein E and lipoprotein lipase

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Lipoprotein-matrix interactions in macrovascular disease in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Contribution of fatty acids released from lipolysis of plasma triglycerides to total plasma fatty acid flux and tissue-specific fatty acid uptake.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Effect of increased afterload on cardiac lipoprotein lipase and VLDL receptor expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

In muscle-specific lipoprotein lipase-overexpressing mice, muscle triglyceride content is increased without inhibition of insulin-stimulated whole-body and muscle-specific glucose uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Subtype-specific beta-adrenoceptor signaling pathways in the heart and their potential clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Lipoprotein lipase (LpL) on the surface of cardiomyocytes increases lipid uptake and produces a cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPENDO.00588.2004

10.1152/AJPENDO.00588.2004

21 January 2018

Identifiers

DOI

1 reference

release_cf4h4geftvdxvdpgoetpqee5jm

1 November 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/cf4h4geftvdxvdpgoetpqee5jm

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference